PROMILIAD BIOPHARMA, INC.

Company Information

Company Name
PROMILIAD BIOPHARMA, INC.
Address

ALBERTON, MT, 59820-0010
Phone
n/a
URL
n/a
DUNS
130194082
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$684,959.00
3
STTR Phase I
$707,264.00
4
STTR Phase II
$2,516,144.00
2
Chart code to be here

Award List

  1. Natural feedstocks for diversity oriented synthesis

    Amount: $100,024.00

    DESCRIPTION (provided by applicant): This STTR application requests funds to support the transfer of specific synthetic expertise and methodologies from the Wright Group at Dartmouth College to inves ...

    STTR Phase I 2004 Department of Health and Human Services
  2. Natural feedstocks for diversity-oriented synthesis

    Amount: $998,280.00

    DESCRIPTION (provided by applicant): This Phase II STTR application is a continuation of a previous Phase I award between the Wright group at Dartmouth College and Promiliad Biopharma. The goal of thi ...

    STTR Phase II 2006 Department of Health and Human Services
  3. Fermentation initiated antibiotic synthesis

    Amount: $137,162.00

    DESCRIPTION (provided by applicant): This Phase I Small Business Technology Transfer study between Promiliad Biopharma Inc. and Ohio University is focused on a clear prototype demonstration of REBACS, ...

    STTR Phase I 2005 Department of Health and Human Services
  4. Potent and selective DHFR inhibitors for treating Cryptosporidiosis

    Amount: $279,271.00

    DESCRIPTION (provided by applicant): This STTR application requests funds to support the transfer of specific biophysical and synthetic expertise from the Anderson and Wright Groups at the University ...

    STTR Phase I 2006 Department of Health and Human Services
  5. Isoindolinones as Antimicrobial Agents

    Amount: $225,624.00

    DESCRIPTION (provided by applicant): Antibiotic resistance among common pathogens is a serious public health problem because it compromises our ability to treat many infectious diseases. The problem h ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. New antibiotics targeting fatty acid biosynthesis

    Amount: $171,569.00

    DESCRIPTION (provided by applicant): Antibiotic resistant pathogens, such as methicillin-resistant Staphylococcus aureus, are a significant public health problem which is compounded by the slow rate o ...

    SBIR Phase I 2009 Department of Health and Human Services
  7. The identification of novel negative allosteric modulators of the nicotinic recep

    Amount: $190,807.00

    DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to identify novel negative allosteric modulators of the nicotinic acetylcholine receptor. This project seeks to partner th ...

    STTR Phase I 2009 Department of Health and Human Services
  8. Potent Antifolates as New Therapeutics for MRSA

    Amount: $1,517,864.00

    DESCRIPTION (provided by applicant): This Phase II STTR proposal describes a collaborative effort between researchers in the Department of Pharmaceutical Sciences at the University of Connecticut and ...

    STTR Phase II 2010 Department of Health and Human Services
  9. Selective MRTF/SRF-Transcription Inhibitors: Novel Anti-fibrotics for IPF

    Amount: $287,766.00

    DESCRIPTION: Antibiotic resistance among common bacterial pathogens is a serious public health problem as it compromises our ability to treat infectious disease. The resistance problem is compounded ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government